The FDA has approved a new omega-3 supplement (brand name, Epanova) to
treat adults with severe hypertriglyceridemia, defined as triglyceride
levels 500 mg/dL or higher.
In its announcement, the manufacturer said that Epanova is the first
omega-3 formulation approved by the FDA in free fatty acid form. It
will be available in 1-g capsules and has been approved for 2-g and 4-
g dosages, which can be taken with or without food.
There are currently two other prescription formulations of omega-3
supplements on the market: Lovaza and Vascepa. All three are approved
only for the treatment of severe hypertriglyceridemia, though studies
of expanded indications are underway.
By Larry Husten